News & Articles

Chinese Proprietary Medicines(中成药产品)  refers to finished medicinal  product, such as a capsule or tablet, and contains one or more active ingredients from any plant, animal or mineral, or any combination of sources. All the active ingredients must be documented for use in traditional Chinese medicine. Prior to importation and distribution of CPM in Singapore, CPM […]

Cell, tissue, gene therapy product (CTGTP) are health products intended for use in humans for a therapeutic, preventive, palliative or diagnostic purpose. CTGTP can contain any of the following and achieves its primary intended action by pharmacological, immunological, physiological, metabolic or physical means. CTGTP products are divided into 2 classes namely: Class 1 CTGTP product […]

Cosmetic products are substances or mixtures intended for application to the external parts of the body, such as the skin, hair, nails, lips and teeth, for purposes including cleansing, perfuming, protecting or enhancing appearance. In Singapore, cosmetic products are regulated by the Health Sciences Authority and are subject to a mandatory cosmetic product notification prior […]

At present, health supplements in Singapore are not subject to pre-market approval prior to importation. While notification may be performed on a voluntary basis, companies often misinterpret this as an absence of regulatory requirements. In practice, this perception can be misleading. Companies importing health supplements remain fully responsible for ensuring that their products comply with […]

Registration of a medical product starts with an official classification  which will determine the documentary requirements, timelines, and fees. Today we are going to share a few misconceptions and the approach to classify a product correctly. Misconception We assume that the classification in the country of origin will be the classification in the country to […]

As pharmaceutical companies worldwide continue to expand their global reach, navigating the intricate landscape of international markets becomes an increasingly complex endeavour. In this era of heightened regulatory scrutiny, pharma companies must be well-versed in the multifaceted world of regulatory affairs in order to successfully expand their operations beyond borders. We’ll explore the indispensable role […]